CSF3 and pulmonary fibrosis: However, when the dose of G-CSF was up to 60 μg/kg, no significant inhibitory effect on BLM-induced lung fibrosis was observed in the treatment groups (Supplementary figure 1), indicating that a relative low dose was critical for the antifibrotic effect of G-CSF.